Publications 2005
Isolation, Catalytic Properties and Competitive Inhibitors of the Zinc-dependent Murine Glutaminyl Cyclase
Stephan Schilling; Holger Cynis; Alex von Bohlen; Torsten Hoffmann; Michael Wermann; Ulrich Heiser; Mirko Buchholz; Katrin Zunkel; Hans-Ulrich Demuth
Biochemistry 2005 (44) 13415-13424
Brain prolyl endopeptidase expression in aging, APP transgenic mice and Alzheimer’s disease.
Steffen Roßner; Ingo Schulz; Ulrike Zeitschel; Reinhard Schliebs; Volker Bigl; Hans-Ulrich Demuth
Neurochem. Res. 2005 (30) 695-702
Type 2 Diabetes - Therapy with Dipeptidyl Peptidase IV Inhibitors.
H.-U. Demuth; C.H.S. McIntosh; R.A. Pederson
Biochim. Biophys. Acta - Proteins and Proteomics 2005 (1751) 33-44
Subcellular localization suggests novel functions for prolyl endopeptidase.
Ingo Schulz; Ulrike Zeitschel; Thomas Rudolph; Bernd Gerhartz; Volker Bigl; Hans-Ulrich Demuth, Steffen Roßner
J. Neurochem. 2005 (94) 4, 970-979
Dipeptidyl peptidase IV inhibitors: how do they work as new antidiabetic agents?
McIntosh, CHS.; Demuth, H.-U.; Pospisilik, J.A.; Pederson, R.A.
Regulatory Peptides 2005 (128) 2, 159-165
Improvement of glucose tolerance in Zucker diabetic fatty rats by long-term treatment with the dipeptidyl peptidase inhibitor P32/98: comparison with and combination with rosiglitazone.
E. Wargent; C. Stocker; P. Augstein; P. Heinke; A. Meyer; T. Hoffmann; A. Subramanian; M.V. Sennitt; H.-U. Demuth; J.R.S. Arch; M.A. Cawthorne
Diabetes, Obesity and Metabolism 2005 (7) 170-181